SMTL ID : 6vne.2 (1 other biounit)

JAK2 JH1 in complex with Fedratinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

monomer

Ligands

1 x 2TA: N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide(Non-covalent)

2TA.1: 18 residues within 4Å: Chain A: Q.29, Q.30, L.31, G.32, G.34, G.37, V.39, A.56, K.58, M.105, E.106, Y.107, L.108, G.111, R.156, N.157, L.159, D.170 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.31, A:L.31, A:V.39, A:V.39, A:A.56, A:Y.107, A:L.159 Hydrogen bonds: A:L.108, A:L.108, A:N.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-02-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence